MENU

EW Stock Tickeron detected bearish Stock Pattern: Cup-and-Handle Inverse EW on January 13, 2025, netting in a 4.91% gain over 1 week

A.I.dvisor
at Tickeron.com
Loading...
+4.91% Gain from a Successful pattern Cup-and-Handle Inverse
EW - Edwards Lifesciences Corp
Tickeron
Ticker: EW
Company: Edwards Lifesciences
Gain from shortening: +4.91%
Confirmed: 01/13/25
Succeeded: 01/15/25
Total length: 12 days
On January 03, 2025, A.I.dvisor detected a Cup-and-Handle Inverse Pattern (Bearish) for Edwards Lifesciences Corp (EW, $73.91). 10 days later, on January 13, 2025, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On January 15, 2025, the stock hit the target price of $69.48 – resulting in a gain for traders who shorted the stock on the pattern detection date.

EW sees MACD Histogram crosses below signal line

EW saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 30, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on EW as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

EW moved below its 50-day moving average on January 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EW advanced for three days, in of 321 cases, the price rose further within the following month. The odds of a continued upward trend are .

EW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 260 cases where EW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.532) is normal, around the industry mean (23.475). P/E Ratio (40.978) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (5.416) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (9.569) is also within normal values, averaging (41.274).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
EW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of products to treat late-stage cardiovascular disease

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Edwards Way
Phone
+1 949 250-2500
Employees
19800
Web
https://www.edwards.com